2
guidelines regarding the safety, efficacy, and sustainability of medicinal plant material being
used in herbal medicines.
(i) “Good manufacturing practices” or “GMP” means the Food and Drug Administration’s
formal regulations regarding the design, monitoring, control, and maintenance of manufacturing
processes and facilities. They are designed to ensure that products manufactured are to specific
requirements including identity, strength, quality, and purity.
(j) “Harvest batch” means a designated quantity of harvested marihuana, all of which is
identical in strain and has been grown and harvested together and exposed to substantially
similar conditions throughout cultivation.
(k) "Immature plant” means a nonflowering marihuana plant that is no taller than 8 inches from
the growing or cultivating medium and no wider than 8 inches produced from a cutting, clipping,
tissue culture, or seedling that is in a growing or cultivating medium or in a growing or
cultivating container.
(l) “Inactive ingredients” means binding materials, dyes, preservatives, flavoring agents, and
any other ingredient that is not derived from the plant Cannabis Ssativa L.
(m) “Laboratory” refers to both a safety compliance facility under the medical marihuana
facilities licensing act and a marihuana safety compliance facility under the Michigan
rRegulation and tTaxation of mMarihuana aAct.
(n) “Limit of quantitation” or “LOQ” means the minimum concentration or mass of an analyte
in a given matrix that can be reported as a quantitative result.
(o) “Marihuana business” refers to a marihuana facility under the medical marihuana facilities
licensing act or a marihuana establishment under the Michigan rRegulation and tTaxation of
mMarihuana aAct, or both.
(p) “Marihuana establishment” means a location at which a licensee is licensed to operate a
marihuana grower, marihuana safety compliance facility, marihuana processor, marihuana
microbusiness, class A marihuana microbusiness, marihuana retailer, marihuana secure
transporter, marihuana designated consumption establishment, or any other type of marihuana-
related business licensed to operate by the agency under the Michigan rRegulation and tTaxation
of mMarihuana aAct.
(q) “Marihuana facility” means a location at which a licensee is licensed to operate under the
medical marihuana facilities licensing act.
(r) “Marihuana product” means marihuana or a marihuana-infused product, or both, as those
terms are defined in the act unless otherwise provided for in these rules.
(s) “Marihuana sales location” refers to a provisioning center under the medical marihuana
facilities licensing act or a marihuana retailer under the Michigan rRegulation and tTaxation of
mMarihuana aAct, or both.
(t) “Marihuana tracking act” means the marihuana tracking act, 2016 PA 282, MCL 333.27901
to 333.27904.
(u) “Medical marihuana facilities licensing act” or “MMFLA” means the medical marihuana
facilities licensing act, 2016 PA 281, MCL 333.27101 to 333.27801.
(v) “Michigan rRegulation and tTaxation of mMarihuana aAct” or “MRTMA” means the
Michigan Regulation and Taxation of Marihuana Act, 2018 IL 1, MCL 333.27951 to 333.27967.
(w) “Package tag” means an RFID tag supplied through the statewide monitoring system for
the purpose of identifying a package containing a marihuana product.
(x) “Plant tag” means an RFID tag supplied through the statewide monitoring system for the
purpose of identifying an individual marihuana plant.